Vericiguat attenuates cardiac inflammation and oxidative stress in an obese postmenopausal rat model with concurrent modulation of PKG-I, TGF-β1, and NF-κB
Publication date: Available online 12 November 2026 Source: European Journal of Pharmacology Author(s): Azadeh Shahrokhi Raeini, Mohammad Khaksari, Hamideh Bashiri, Fatemeh Majidpour, Gholamreza Asadikaram
Vericiguat attenuates cardiac inflammation and oxidative stress in an obese postmenopausal rat model with concurrent modulation of PKG-I, TGF-β1, and NF-κB. // Biophysical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S001429992600991X?dgcid=rss_sd_all
Vericiguat attenuates cardiac inflammation and oxidative stress in an obese postmenopausal rat model with concurrent modulation of PKG-I, TGF-β1, and NF-κB. Biophysical Reports. https://www.sciencedirect.com/science/article/pii/S001429992600991X?dgcid=rss_sd_all
“Vericiguat attenuates cardiac inflammation and oxidative stress in an obese postmenopausal rat model with concurrent modulation of PKG-I, TGF-β1, and NF-κB.” Biophysical Reports.
@article{article11228,
title = {Vericiguat attenuates cardiac inflammation and oxidative stress in an obese postmenopausal rat model with concurrent modulation of PKG-I, TGF-β1, and NF-κB},
journal = {Biophysical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S001429992600991X?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...